146 related articles for article (PubMed ID: 11679140)
1. Differential effects of acute and chronic wound fluids on urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and tissue-type plasminogen activator in cultured human keratinocytes and fibroblasts.
Weckroth M; Vaheri A; Myöhänen H; Tukiainen E; Sirén V
Wound Repair Regen; 2001; 9(4):314-22. PubMed ID: 11679140
[TBL] [Abstract][Full Text] [Related]
2. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.
Weckroth M; Vaheri A; Virolainen S; Saarialho-Kere U; Jahkola T; Sirén V
Br J Dermatol; 2004 Dec; 151(6):1189-96. PubMed ID: 15606514
[TBL] [Abstract][Full Text] [Related]
3. Temporal expression of urokinase plasminogen activator, plasminogen activator inhibitor and gelatinase-B in chronic wound fluid switches from a chronic to acute wound profile with progression to healing.
Wysocki AB; Kusakabe AO; Chang S; Tuan TL
Wound Repair Regen; 1999; 7(3):154-65. PubMed ID: 10417751
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid upregulates the plasminogen activator system in human epidermal keratinocytes.
Braungart E; Magdolen V; Degitz K
J Invest Dermatol; 2001 May; 116(5):778-84. PubMed ID: 11348470
[TBL] [Abstract][Full Text] [Related]
5. Increased migration of murine keratinocytes under hypoxia is mediated by induction of urokinase plasminogen activator.
Daniel RJ; Groves RW
J Invest Dermatol; 2002 Dec; 119(6):1304-9. PubMed ID: 12485432
[TBL] [Abstract][Full Text] [Related]
6. Hyperglycemia is associated with lower levels of urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor in wound fluid.
Akinci B; Terzi C; Sevindik G; Yuksel F; Tunc UA; Tunali S; Yesil S
J Diabetes Complications; 2014; 28(6):844-9. PubMed ID: 25179235
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C mediates up-regulation of urokinase and its receptor in the migrating keratinocytes of wounded cultures, but urokinase is not required for movement across a substratum in vitro.
Ando Y; Jensen PJ
J Cell Physiol; 1996 Jun; 167(3):500-11. PubMed ID: 8655604
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of urokinase-type plasminogen activator (uPA), its receptor (uPA-R), and inhibitor type-2 (PAI-2) during differentiation of keratinocytes in an organotypic coculture system.
Schaefer BM; Stark HJ; Fusenig NE; Todd RF; Kramer MD
Exp Cell Res; 1995 Oct; 220(2):415-23. PubMed ID: 7556451
[TBL] [Abstract][Full Text] [Related]
9. Sphingosylphosphorylcholine stimulates proliferation and upregulates cell surface-associated plasminogen activator activity in cultured human keratinocytes.
Wakita H; Matsushita K; Nishimura K; Tokura Y; Furukawa F; Takigawa M
J Invest Dermatol; 1998 Mar; 110(3):253-8. PubMed ID: 9506444
[TBL] [Abstract][Full Text] [Related]
10. The receptor for urokinase-type plasminogen activator is expressed by keratinocytes at the leading edge during re-epithelialization of mouse skin wounds.
Rømer J; Lund LR; Eriksen J; Pyke C; Kristensen P; Danø K
J Invest Dermatol; 1994 Apr; 102(4):519-22. PubMed ID: 8151132
[TBL] [Abstract][Full Text] [Related]
11. [Effect of vacuum-assisted closure on the expression of urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor in acute and chronic wounds healing].
Li YJ; Cao DY; Chen SZ
Zhonghua Zheng Xing Wai Ke Za Zhi; 2006 Jul; 22(4):306-9. PubMed ID: 17017150
[TBL] [Abstract][Full Text] [Related]
12. Interaction of urokinase A chain with the receptor of human keratinocytes stimulates release of urokinase-like plasminogen activator.
Fibbi G; Magnelli L; Pucci M; Del Rosso M
Exp Cell Res; 1990 Mar; 187(1):33-8. PubMed ID: 2153567
[TBL] [Abstract][Full Text] [Related]
13. The receptor for urokinase-type plasminogen activator of a human keratinocyte line (HaCaT).
Reinartz J; Link J; Todd RF; Kramer MD
Exp Cell Res; 1994 Oct; 214(2):486-98. PubMed ID: 7925643
[TBL] [Abstract][Full Text] [Related]
14. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
[TBL] [Abstract][Full Text] [Related]
15. The role of the urokinase-type plasminogen activator (uPA) and its receptor (CD87) in lipodermatosclerosis.
Herouy Y; Aizpurua J; Stetter C; Dichmann S; Idzko M; Hofmann C; Gitsch G; Vanscheidt W; Schöpf E; Norgauer J
J Cutan Pathol; 2001 Jul; 28(6):291-7. PubMed ID: 11401675
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of plasminogen activation in normal keratinocytes and SCC-4 cells by fibroblasts.
Boxman IL; Quax PH; Löwik CW; Papapoulos SE; Verheijen J; Ponec M
J Invest Dermatol; 1995 Mar; 104(3):374-8. PubMed ID: 7861005
[TBL] [Abstract][Full Text] [Related]
17. Collagen dissolution by keratinocytes requires cell surface plasminogen activation and matrix metalloproteinase activity.
Netzel-Arnett S; Mitola DJ; Yamada SS; Chrysovergis K; Holmbeck K; Birkedal-Hansen H; Bugge TH
J Biol Chem; 2002 Nov; 277(47):45154-61. PubMed ID: 12192005
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activation in healing human wounds.
Schäfer BM; Maier K; Eickhoff U; Todd RF; Kramer MD
Am J Pathol; 1994 Jun; 144(6):1269-80. PubMed ID: 8203466
[TBL] [Abstract][Full Text] [Related]
19. Secretion of urokinase and tissue-plasminogen activator by epidermal cells in the presence of psoriatic fibroblast-conditioned medium.
Horiuchi Y; Marshall JM; Cederholm-Williams SA; Ryan TJ
Acta Derm Venereol; 1992 Nov; 72(6):401-2. PubMed ID: 1362828
[TBL] [Abstract][Full Text] [Related]
20. A high-affinity receptor for urokinase plasminogen activator on human keratinocytes: characterization and potential modulation during migration.
McNeill H; Jensen PJ
Cell Regul; 1990 Oct; 1(11):843-52. PubMed ID: 1965151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
